DermatoFibroSarcoma Protuberans (DFSP) is a rare recurrent fibrohistiocytic tumor. Given the limitation of available diagnostic modalities in a resource poor setting, diagnosis can be confusing. As most of the tumors recur with time, our case of complete cure was interesting phenomenon observed in our case.
Background: Scabies is one of the most common causes of dermatology outpatient visits. Scabies can cause significant impairment in quality of life of patients.Methods: All consenting patients with Scabies presenting to the clinic from April 2021 to April 2022 were enrolled in this observational study. Clinical evaluation for scabies, sites involved and patient demographics was recorded. All participants were asked to complete the Nepali Dermatology Life Quality Index (DLQI) questionnaire.Results: This study included 119 patients. Of these, 76.5% were males, 61.3% were living single and 57.1% were students. The mean age of the study population was 24.69 ± 8.74 years. Almost half of the patients (42.8%) had had scabies for more than 1 month; a similar number of patients had at least one other member of the family with similar symptoms. The overall impairment in quality of life (QoL) was 'very large' with a total DLQI score of 12.91 ± 5.93. Conclusions: Scabies exerts a strong impact on the quality of life of patients.Our study showed that almost half of the patients had a disease duration of more than 1 month.
DERMATOFIBROSARCOMAPROTUBERANS (DFSP) is a rare recurrent
fibrohistiocytic tumor. Given the limitation of available diagnostic
modalities in a resource poor setting, diagnosis can be confusing. As
most of the tumors recur with time, our case of complete cure was
interesting phenomenon observed in our case
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.